Prescription and indications for the use of fluoroquinolones in a group of outpatients in Colombia
Abstract
Introduction: There is evidence of the indiscriminate use of antibiotics for different pathologies.
Objective: To determine the prescription patterns and indications for the use of fluoroquinolones in a group of outpatients in Colombia.
Materials and methods: We conducted a descriptive pharmaco-epidemiological study on prescription-indication using a population database where patients with outpatient
fluoroquinolone prescriptions were included from May to October, 2018. We obtained the information on sociodemographic, pharmacological, and clinical variables, as well as on the diagnosis according to the International Classification of Diseases, version 10, and we established if the use was approved by the regulatory agencies or if it was off-label.
Results: A total of 23,373 patients were identified who were using fluoroquinolones; their mean age was 47.9 ± 18.1 years and women predominated (n=15,767, 67.5%). Ciprofloxacin was the medication most commonly prescribed (n=19,328, 82.7%), followed by norfloxacin (n=3076, 13.2%), levofloxacin (n=573, 2.5%), and moxifloxacin (n=394; 1.7%). The main indications were urinary tract infection in unspecified site (n=10,777, 46.1%), diarrhea and gastroenteritis of presumed infectious origin (n=3077, 13.2%), and acute cystitis (n=956; 4.2%). The prescriptions followed approved indications in 76% (n=17,759) of cases while the rest were used off-label or without indication for nasopharyngitis or soft-tissue infections, for example. Being male (OR=1.26, 95%CI:1.18-1.34) and under 35 years of age (OR=1.92, 95%CI:1.48-1.50) were associated with a greater probability of using fluoroquinolones in unapproved indications.
Conclusions: Fluoroquinolones, particularly ciprofloxacin, are being prescribed especially to women with urinary tract infections, but up to a quarter of the patients received them for unapproved indications by regulatory agencies.
Downloads
References
CDC. Antibiotic use in the United States, 2017: Progress and opportunities. Atlanta, GA: US Department of Health and Human Services, CDC; 2017. Fecha de consulta: 20 de enero de 2019. Disponible en: https://www.cdc.gov/antibiotic-use/stewardship-report/pdf/stewardshipreport.pdf
Organización Mundial de la Salud. Promoción del uso racional de medicamentos: componentes centrales. Perspectivas políticas sobre medicamentos de la OMS. 2002. Fecha de consulta: 31 de mayo de 2019 Disponible en: https://apps.who.int/medicinedocs/pdf/s4874s/s4874s.pdf
Kabbani S, Hersh AL, Shapiro DJ, Fleming-Dutra KE, Pavia AT, Hicks LA. Opportunities to improve fluoroquinolone prescribing in the United States for adult ambulatory care visits. Clin Infect Dis. 2018;67:134-6. https://doi.org/10.1093/cid/ciy035
Hersh AL, Fleming-Dutra KE, Shapiro DJ, Hyun DY, Hicks LA. Frequency of first-line antibiotic selection among US ambulatory care visits for otitis media, sinusitis, and pharyngitis. JAMA Intern Med. 2016;176:1870-2. https://doi.org/10.1001/jamainternmed.2016.6625
Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G. Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: A systematic review and meta-analysis of observational studies. BMC Infect Dis. 2015;15:545. https://doi.org/10.1186/s12879-015-1282-4
Kabbara WK, Ramadan WH, Rahbany P, Al-Natour S. Evaluation of the appropriate use of commonly prescribed fluoroquinolones and the risk of dysglycemia. Ther Clin Risk Manag. 2015;11:639-47. https://doi.org/10.2147/TCRM.S81280
World Health Organization. Antimicrobial resistance: Global report on surveillance. World Health Organization; 2014. Fecha de consulta: 20 de enero de 2019. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_eng.pdf;jsessionid=5A9FF7C6F7F6C574BFF16F0F8EAB7FA7?sequence=1
Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment, Ahmad N, Ahuja SD, Akkerman OW, Alffenaar J-WC, Anderson LF, et al. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: An individual patient data meta-analysis. Lancet. 2018;392:821-34.
https://doi.org/10.1016/S0140-6736(18)31644-1
World Health Organization. Critically important antimicrobials for human medicine: Ranking of antimicrobial agents for risk management of antimicrobial resistance due to non-human use. World Health Organization; 2017. Fecha de consulta: 20 de enero de 2019. Disponible en: http://apps.who.int/medicinedocs/documents/s22251en/s22251en.pdf
World Health Organization. Monitoring and evaluation of the global action plan on antimicrobial resistance (AMR): Regional expert consultation on monitoring and evaluation of AMR interventions. Washington, D.C.: World Health Organization; 2017. Fecha de consulta: 20 de enero de 2019. Disponible en: http://www.fao.org/3/a-i7711e.pdf
Hicks LA, Bartoces MG, Roberts RM, Suda KJ, Hunkler RJ, Taylor TH, Jr., et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clin Infect Dis. 2015;60:1308-16. https://doi.org/10.1093/cid/civ076
Machado-Alba JE, González-Santos DM. Dispensación de antibióticos de uso ambulatorio en una población colombiana. Revista de Salud Pública. 2009;11:734-44.
López JJ, Garay AM. Estudio de utilización de antibióticos en el servicio de consulta externa de un hospital público en Bogotá, DC. Revista Colombiana de Ciencias Químicas y Farmacéuticas. 2016;45:35-47. https://doi.org/10.15446/rcciquifa.v45n1.58014
Redgrave LS, Sutton SB, Webber MA, Piddock LJ. Fluoroquinolone resistance: Mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 2014;22:438-45. https://doi.org/10.1016/j.tim.2014.04.007
Peters S. FDA issues new fluoroquinolone safety warnings and prescribing restrictions. S D Med. 2016;69:418-21.
European Association of Urology. Guidelines on urological infections 2015. Fecha de consulta: 20 de enero de 2019. Disponible en: https://uroweb.org/wp-content/uploads/19-Urological-infections_LR2.pdf
European Medicines Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics United Kingdom 2018. Fecha de consulta: 20 de enero de 2019. Disponible en: https://www.ema.europa.eu/en/documents/press-release/disabling-potentially-permanent-side-effects-lead-suspensionrestrictions-quinolone-fluoroquinolone_en.pdf
Raff AB, Kroshinsky D. Cellulitis: A review. JAMA. 2016;316:325-37. https://doi.org/10.1001/jama.2016.8825
Sandoval-Paredes J, Sandoval-Paz C. Uso de fármacos durante el embarazo. Horizonte Médico. 2018;18:71-9. https://doi.org/10.24265/horizmed.2018.v18n2.11
Bar-Oz B, Moretti ME, Boskovic R, O’Brien L, Koren G. The safety of quinolones--a metaanalysis of pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol. 2009;143:75-8. https://doi.org/10.1016/j.ejogrb.2008.12.007
American Pharmacists Association. Drug Information Handbook. 27th edition. Washington, D.C.: Lexicomp; 2018-2019. p. 503-8.
Almalki ZS, Alahmari AK, Guo JJ, Cavanaugh TM. Off-label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006 to 2012. Pharmacoepidemiol Drug Saf. 2016;25:1042-51. https://doi.org/10.1002/pds.4021
Ray MJ, Tallman GB, Bearden DT, Elman MR, McGregor JC. Antibiotic prescribing without documented indication in ambulatory care clinics: National cross sectional study. BMJ. 2019;367:l6461. https://doi.org/10.1136/bmj.l6461
Suzuki H, Perencevich EN, Alexander B, Beck BE, Goto M, Lund BC, et al. Inpatient fluoroquinolone stewardship improves the quantity and quality of fluoroquinolone-prescribing at hospital discharge: A retrospective analysis among 122 Veterans Health Administration Hospitals. Clin Infect Dis. 2019. https://doi.org/10.1093/cid/ciz967
Ministerio de Salud y Protección Social. Decreto Número 780 de 2016 Colombia 2016. Fecha de consulta: 20 de enero de 2019. Disponible en: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/decreto-780-unico-modificado-2016.pdf
Machado-Alba JE, Machado-Duque ME, Alzate-Carvajal V. Drugs prescribed by medical students: A suitable practice? Public Health. 2015;129:579-81. https://doi.org/10.1016/j.puhe.2015.01.027
Vacca CP, Niño CY, Reveiz L. Restriction of antibiotic sales in pharmacies in Bogotá, Colombia: A descriptive study. Rev Panam Salud Pública. 2011;30:586-91.
Simó S, Fraile D, Sánchez A, García-Algar O. Dispensing of over-the-counter drugs in pharmacies. An Pediatr (Barc). 2013;79:10-4. https://doi.org/10.1016/j.anpedi.2012.10.015
Montúfar FE, Varón FA, Giraldo LF, Sáenz ÓA, Rodríguez A, Alarcón AM, et al. Recomendaciones para el diagnóstico, tratamiento y prevención de la neumonía adquirida en la comunidad en adultos inmunocompetentes. Infectio. 2013;17(1S). https://doi.org/0.1016/S0123-9392(13)70019-5
Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC. α-blockers, antibiotics and antiinflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome. BJU Int. 2012;110:1014-22. https://doi.org/10.1111/j.1464-410X.2012.11088.x
Wang J, Wang P, Wang X, Zheng Y, Xiao Y. Use and prescription of antibiotics in primary health care settings in China. JAMA Intern Med. 2014;174:1914-20. https://doi.org/10.1001/jamainternmed.2014.5214
Some similar items:
- Giovanny Montoya, Claudia Vaca, María Fernanda Parra, Adverse events associated with tramadol and dipirona administration in a level III hospital , Biomedica: Vol. 29 No. 3 (2009)
- César A. Arias, Marylin Hidalgo, Jinnethe Reyes, Ana María Cárdenas, Lorena Díaz, Sandra Ríncon, Natasha Vanegas, Paula Lucía Díaz, Elizabeth Castañeda, Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci , Biomedica: Vol. 28 No. 2 (2008)
- Alvaro Vallejos, Adverse reactions by antibiotics in a pediatric and neonatal intensive care unit located in Bogotá, Colombia , Biomedica: Vol. 27 No. 1 (2007)
- Gabriel Tribiño, Carlos Maldonado, Omar Segura, Jorge Díaz, Direct costs and clinical aspects of adverse drug reactions in patients admitted to a level 3 hospital internal medicine ward. , Biomedica: Vol. 26 No. 1 (2006)
- Jorge E. Machado-Alba, Cristhian David Morales-Plaza, Antipsychotic prescription patterns in patients affiliated to the Social Security Health System in Colombia , Biomedica: Vol. 33 No. 3 (2013)
- Jorge E. Machado-Alba, Luis Felipe Echeverri-Cataño, Manuel José Londoño-Builes, Paula Andrea Moreno-Gutiérrez, Sergio Andrés Ochoa-Orozco, Joaquín Octavio Ruiz-Villa, Social, cultural and economic factors associated with self-medication , Biomedica: Vol. 34 No. 4 (2014)
- Manuel Enrique Machado-Duque, Catalina Alzate-Carvajal, Kevin Zapata-Castañeda, Jorge Enrique Machado-Alba, Profile of lithium carbonate use in patients with bipolar disorder in Colombia , Biomedica: Vol. 37 No. Sup.1 (2017): Suplemento 1, Alteraciones del sistema nervioso
- Jorge E. Machado-Alba, Miguel A. Atehortua-Otero, Diego A. Cortés-Mejía, Profile of antiretroviral agents use in Colombia , Biomedica: Vol. 38 No. 4 (2018)
- Jorge Enrique Machado-Alba, Luis Felipe Calvo-Torres, Andrés Gaviria-Mendoza, Juan Daniel Castrillón-Spitia, Prescribing patterns of antiparkinson drugs in a group of Colombian patients, 2015 , Biomedica: Vol. 38 No. 3 (2018)
- Andres Gaviria-Mendoza, Manuel E. Machado-Duque, Jorge E. Machado-Alba, Lipid-lowering drug prescriptions in a group of Colombian patients , Biomedica: Vol. 39 No. 4 (2019)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
